Skip to content
BidBenchmark
SolicitationAmendment 2

Serological Assays for the Detection and Characterization of Influenza Viruses

CDC OFFICE OF ACQUISITION SERVICES · Atlanta, Georgia

View authoritative SAM noticeSign in to watch

Response status

Historical record

Feb 7, 2025, 7:00 PM UTC

This notice is no longer open.

Posted
Jan 16, 2025
Archive date
May 15, 2025
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • CDC OFFICE OF ACQUISITION SERVICES published this solicitation.
  • The place of performance is Atlanta, Georgia.
  • The notice uses NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing).

Procurement identity

Notice ID
6b47917eb3754328bd9dd39cd0e235ec
Solicitation
75D30125R73235
Base type
Solicitation
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Solicitation
Solicitation number
75D30125R73235
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
PSC
Q301 — REFERENCE LABORATORY TESTING
Set-aside
—
Set-aside code
—
Posted
Jan 16, 2025
Responses due
Feb 7, 2025, 7:00 PM UTC
Archive date
May 15, 2025
Archive type
autocustom
Base type
Solicitation
Organization type
OFFICE
Benchmark category
—
Category confidence
—
Category source
—
Last seen
Aug 29, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Department code
—
Subagency
Centers for Disease Control and Prevention
Subagency code
—
Office
CDC OFFICE OF ACQUISITION SERVICES
Organization path
—
Organization path codes
—
Office address
ATLANTA, GA, 30333, USA
Place of performance
Atlanta, Georgia
City code
—
State
Georgia
State code
GA
Postal code
—
Country
—

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. This is Phase I of a a two phased multi-step mandatory down select solicitation. Interest for Phase I is due to the contracting officer no later than 2:00 PM EST February 7, 2025. The steps in Phase I are as follows: Letter of Interest � offerors shall email POC information to Contracting Officer Proficiency panel will be sent by CDC to intersted offerors Vendor shall email results to CDC Contracting Officer CDC Contractng Officer will notify each offeror of their pass/fail status for Phase I and if they are then able to proceed to Phase II

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

No past awards scored highly enough to form a comparable range.

Comparable awards

The match score is decomposed so each comparison can be challenged.

No comparable awards are attached to this notice.

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1SolicitationAug 10, 2026Feb 7, 2025, 7:00 PM UTC643d22459ffaf18f
2SolicitationAug 28, 2026Feb 7, 2025, 7:00 PM UTC2e3e1240ee0d7daa

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
city_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
country_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
state_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Aug 29, 2026. SAM.gov remains authoritative.

Note 1 covers the solicitation record. No synthetic FAQ or inferred solicitation value is published.

Serological Assays for the Detection and Characterization of Influenza Viruses — federal contract opportunity · BidBenchmark